| Product Code: ETC6736280 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China import of alteplase in 2024 saw a significant increase with top exporting countries being the USA, Sweden, Japan, UK, and Canada. The high Herfindahl-Hirschman Index (HHI) concentration indicates a competitive market. The Compound Annual Growth Rate (CAGR) from 2020 to 2024 was strong at 7.98%, with a notable growth rate of 11.82% in 2023-24. This suggests a growing demand for alteplase in China and a flourishing market for importers to capitalize on.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Alteplase Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Alteplase Market Revenues & Volume, 2021 & 2031F |
3.3 China Alteplase Market - Industry Life Cycle |
3.4 China Alteplase Market - Porter's Five Forces |
3.5 China Alteplase Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Alteplase Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Alteplase Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 China Alteplase Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Alteplase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of stroke cases in China |
4.2.2 Growing awareness and adoption of alteplase in treating acute ischemic stroke |
4.2.3 Favorable government initiatives and policies promoting stroke treatment |
4.3 Market Restraints |
4.3.1 High cost associated with alteplase treatment |
4.3.2 Limited accessibility to alteplase in rural areas of China |
4.3.3 Concerns regarding potential side effects and risks associated with alteplase therapy |
5 China Alteplase Market Trends |
6 China Alteplase Market, By Types |
6.1 China Alteplase Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Alteplase Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 China Alteplase Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 China Alteplase Market Revenues & Volume, By Solution, 2021- 2031F |
6.1.5 China Alteplase Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Alteplase Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Alteplase Market Revenues & Volume, By Acute Ischemic Stroke, 2021- 2031F |
6.2.3 China Alteplase Market Revenues & Volume, By Acute Myocardial Infarction, 2021- 2031F |
6.2.4 China Alteplase Market Revenues & Volume, By Acute Massive Pulmonary Embolism, 2021- 2031F |
6.2.5 China Alteplase Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Alteplase Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 China Alteplase Market Revenues & Volume, By Clinic, 2021- 2031F |
6.3.3 China Alteplase Market Revenues & Volume, By Hospital, 2021- 2031F |
6.3.4 China Alteplase Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Alteplase Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Alteplase Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 China Alteplase Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 China Alteplase Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Alteplase Market Import-Export Trade Statistics |
7.1 China Alteplase Market Export to Major Countries |
7.2 China Alteplase Market Imports from Major Countries |
8 China Alteplase Market Key Performance Indicators |
8.1 Number of certified stroke centers in China offering alteplase treatment |
8.2 Rate of adoption of alteplase as a first-line treatment for acute ischemic stroke |
8.3 Number of ongoing clinical trials evaluating the efficacy and safety of alteplase in stroke treatment |
9 China Alteplase Market - Opportunity Assessment |
9.1 China Alteplase Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Alteplase Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Alteplase Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 China Alteplase Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Alteplase Market - Competitive Landscape |
10.1 China Alteplase Market Revenue Share, By Companies, 2024 |
10.2 China Alteplase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here